Freya Biosciences
PrivateLast Round
Series A
Extension
Nov 19, 2024
Total Funding Raised
$49.8M
Company Overview
Freya Biosciences is a biotechnology company specializing in the development of microbial immunotherapies to meet significant unmet medical needs across various indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Freya Biosciences Comps
Public and private peers based on sector, stage, and business model.
Freya Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 19, 2024 | ||||
| Series A | Dec 11, 2023 |
Key People
Founding team and executive leadership
Freya Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Corundum Systems Biology | Series A |
| The Bill & Melinda Gates Foundation Trust | Series A Extension |
| Angelini Ventures | Series A |
| Sofinnova Partners | Series A |
| OMX Ventures | Series A |
Freya Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Freya Biosciences's valuation, stock price, and market status.
